| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2877873 | The Annals of Thoracic Surgery | 2011 | 11 Pages |
Abstract
Respectable survival can be achieved after neoadjuvant chemoradiation, followed by anatomic resection, in selected patients with clinically advanced NSCLC. A T0 primary tumor or N0 lymph node status individually, or together as a complete response (T0 N0) status, is associated with the best long-term survival. Survival is most favorable for lobectomies vs pneumonectomies after neoadjuvant chemoradiation therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anthony W. MD, Michael J. MD, Philip MD, William H. MD, Sanjib PhD, Erin C. MD, L. Penfield MD,